אפידמיולוגיה
סרטן וקרינה
מנהלת היחידה
צוות היחידה
מחקרים
פרסומים
מרכז ידע בנושא קרינה בלתי מייננת
מחלות לב וכלי דם
בריאות האישה והילד
היבטים פסיכו-סוציאליים של בריאות
מחלות זיהומיות בקהילה
פרסומים גירסה להדפסה

PUBLICATIONS:

1. Farine D, Fox HE, Jackobson S, Timor-Tritsch IE. Vaginal ultrasound for

diagnosis of placenta Previa. Am J Obstet Gynecol 1988; 159: 566-569.

 

2. Farine D, Fox HE, Jackobson S, Timor-Tritsch IE. Is it really a placenta

Previa. Eur J Obstet Gynecol Rep Biol 1989; 6: 103-108.

148.

 

3. Modan B, Sadetzki S. Epidemiology of cancer of the female genital system.

Bama, Publication for Health Workers 1993;7:3-7.

 

4. Modan B, Shpilberg O, Baruch Y, Sikuler E, Anis E, Ashur Y, Chetrit A,

Luxenburg O, Rosenberg E, Rosenthol N, Sadetzki S, Benaim H, Eckstein H,

Shouval D. The need for liver transplantation: a nationwide estimate based on

consensus review. Lancet 1995; 346: 660-662.

 

5. Blumenfeld Z, Shen-Orr Z, Har'el H, Jackobson-Sadetzki S, Ruach M, Ish-Shalom S, Zinder O. Corticotropin-Releasing factor and adrenocorticotropin

tests in chronic anovulatory women: Polycystic ovary syndrome, late-onset

congenital adrenal hyperplasia, and acanthosis nigricans. Israel J Obstet

Gynecol 1997; 8: 158-168.

 

6. Sadetzki S, Modan B. A new look at Down Syndrome. Harefuah 1998; 134:

944-945.

 

7. Cardis E, Kilkenny M, for the International Study Group, International Agency

for Research on Cancer. International case-control study of adult brain, head

and neck tumours: results of the feasibility study. Radiat Prot Dosim 1999;

83: 179-183.

 

8. Sadetzki S, Modan B. Epidemiology as a basis for legislation. How far should

epidemiology go? Lancet 1999; 353: 2238-2239.

 

9. Menczer J, Sadetzki S, Murad H, Barda G, Andreev H, Barchana M.

Childhood and adolescent ovarian malignant tumors in Israel. A nationwide

study. Acta Obstet Gynecol Scand 1999; 78:813-817.

 

10. Sadetzki S, Rostmi N, Modan B. Hepatitis A outbreak originating in a day-

care center. A community case report. Eur J Epidemiol 1999; 15: 549-551.

 

11. Sadetzki S, Chetrit A, Akstein E, Luxenburg O, Keinan L, Litvak I, Modan B.

Risk factors for infant mortality in Down Syndrome. A nationwide study.

Peadiatr Perinat Epidemiol 1999; 13: 442-451.

 

12. Orgad Sh, Loewenthal R, Gaziit E, Sadetzki S, Novikov I, Carp H. The

prognostic value of anti-paternal antibodies and leukocyte immunizations on

the proportion of live birth in couples with consecutive recurrent miscarriages.

Hum Reprod 1999; 14: 2974-9.

 

13. Sadetzki S, Modan B, Chetrit A. Freedman L. An iatrogenic epidemic of

benign meningioma. Am J Epidemiol. 2000; 151: 266-272.

 

14. Geyer O, Neudorfer M, Michaeli-Cohen A, Lazar M, Sadetzki S, Modan B.

Radiation induced Chandler's Syndrome. IMAJ 2000; 2: 241-242.

 

15. Modan B, Keinan L, Blumstein T, Sadetzki S. Cancer following cardiac

catheterization in childhood. Int J Epidemiol 2000;29:424-428.

 

16. Kershenbaum A, Sadetzki S, Chetrit A, Fuchs Z, Bott-Kanner G, Rosenfeld

J, Modan B. A new approach to blood pressure measurement in the primary

care setting. Br J Gen Pract 2000; 50: 725-726.

 

17. Azizi E, Flint P, Sadetzki S, Solomon A, Lerman Y, Harari G, Pavlotsky F,

Kushelevsky A, Glesinger R, Shani E, Rosenberg L. A graded work site

intervention program for prevention of skin cancer in outdoor workers in Israel

- a longitudinal feasibility study. Cancer Causes Control 2000;11:513-521.

 

18. Sadetzki S, Bensal D, Blumstein T, Novikov I, Modan B. Selected risk

factors for transitional cell bladder cancer. Med Oncol 2000; 17: 179-182.

 

19. Kenet G, Sadetzki S, Murad H, Martinowitz U, Rosenberg N, Gitel S,

Rechavi G, Inbal A. Factor V Leiden & Antiphospholipid antibodies are

significant risk factors for ischemic stroke in children. Stroke 2000; 31: 1283-

1288.

 

20. Sadetzki S, Modan B. Cellular phones prosperity or carcinogenesis.

Harefuah 2000; 139: 360-362.

 

21. Sadetzki S, Chetrit A, Akstein E, Keinan L, Luxenburg O, Modan B.

Relinquishment of infants with Down Syndrome in Israel: Trends by time. Am

J Ment Retard 2000; 105: 480-485.

 

22. Elkayam A, Mirelman D, Peleg E, Wilchek M, Miron T, Rabinkov A, Sadetzki

S, Rosenthal T. The effects of allicin and enalapril on blood pressure, insulin

and triglycerides levels in fructose-induced hyperinsulinemic-hyperlipidemic-

hypertensive rats. AJH 2001; 14: 377-381.

 

23. Keinan L, Blumstein T, Sadetzki S, Luxenburg O, Litwak I, Akstein E, Modan

B. Incidence of leukemia and other cancers in Down Syndrome population in

Israel. Int J Cancer 2001; 93: 741-744.

 

24. Schwartz E, Potasman I, Sadetzki S, Almog S, Rotenberg S. Serious

adverse effects of mefloquine in relation to blood level and gender. Am J Trop

Med Hyg 2001; 65: 189-192.

 

25. Schwartz E, Sadetzki S, Murad H, Raveh D. Age as a risk factor for severe

plasmodium falciparum malaria in non-immune patients. Clin Infect Dis 2001;

33: 1774-1777.

 

26. Figer A, Shtoyerman-Chen R, Tamir A, Geva R, Irmin L, Flex D, Theodor L,

Sulkes A, Sadetzki S, Bar-Meir S and Friedman E. Phenotypic

characteristics of colo-rectal cancer in I1307K APC germline mutation

carriers compared with sporadic cases. Br J Cancer 2001; 85: 1368-1371.

 

27. Juven Y, Sadetzki S. A possible association between ionizing radiation and

pituitary adenoma - a descriptive study. Cancer 2002; 95: 397-403.

 

28. Sadetzki S, Flint-Richter P, Ben-Tal T, Nass D. Radiation-induced

meningioma - a descriptive study of 253 cases. J Neurosurg 2002; 97: 1078-

1082.

 

29. Menczer J, Chetrit A, Barda G, Lubin F, Fishler J, Altaras M, Levavi H,

Struewing JP, Sadetzki S, Modan B. Frequency of BRCA mutations in

primary peritoneal carcinoma in Israeli Jewish women. Gynecol Oncol 2003;

88: 58-61.

 

30. Sadetzki S, Calderon-Margalit R, Peretz C, Novikov I, Barchana M, Papa MZ.

Second primary breast and thyroid cancers. Cancer Causes Control 2003;

14: 367-375.

 

31. Murad H, Lavon A, Sadetzki S, Geyer O, Freedman LS. Small samples and

ordered logistic regression: does it help to collapse categories of outcome?

Am Stat 2003; 57: 155-160.

 

32. Refaely Y, Sadetzki S, Chetrit A, Simansky DA, Paley M, Modan B, Yellin

A. The sequence of vessel interruption during lobectomy for non-small cell

lung cancer - is it indeed important? J Thorac Cardiovasc Surg 2003; 125:

1313-1320.

 

33. Modugno F. for the Ovarian Cancer and High-Risk Women Symposium

Presenters, School of Public Health, University of Pittsburgh. Ovarian cancer

and high -risk women: implications of prevention, screening, and early

detection. Gynecol Oncol 2003; 91: 15-31.

 

34. Sadetzki S, Bensal D, Novikov I, Modan B. The limitations of using hospital

controls in cancer etiology - one more example for Berkson's bias. Eur J

Epidemiol 2003; 18: 1127-1131.

 

35. Neudorfer M, Sadetzki S, Anisimova S, Geyer O. Nonpenetrating deep

sclerectomy with the use of adjunctive mitomycin c. Ophthalmic Surg Lasers

Imaging 2004; 35: 6-12.

 

36. Barda G, Menczer J, Chetrit A, Lubin F, Beck D, Piura B, Glezerman M,

Modan B, Sadetzki S. Comparison between primary peritoneal and epithelial

ovarian carcinoma. A population based study. Am J Obstet Gynecol 2004;

190: 1039-1045.

 

37. Sadetzki S, Calderon-Margalit R, Modan B, Srivastava S, Tuttle RM. Ret/ptc

activation in benign and malignant thyroid tumors a rising in a population

exposed to low dose external beam irradiation in childhood. J Clin Endocrinol

Metab 2004; 89: 2281-2289.

 

38. Gal I, Sadetzki S, Gershoni-Baruch R, Oberman B, Carp H, Papa MZ,

Diestelman-Menachem T, Barzilai-Eisenberg S, Friedman E. Offspring

gender ration and rate of recurrent spontaneous miscarriages in Jewish

women at high-risk for breast/ovarian cancer. Am J Hum Genet 2004; 74:

1270-1275.

 

39. Paz A, Sadetzki S, Potasman I. High rates of substance abuse among long-

term travelers to the tropics: an interventional study. J Travel Med 2004; 11:

75-81.

 

40. Leventhal A, Karsenty E, Sadetzki S. Cellualr phones and public health.

Harefuah 2004; 143: 614-618.

 

41. Wolf I, Catane R, Sadetzki S, Karasik A, Kaufman B. Diabetes mellitus and

breast cancer. Lancet Oncol 2005; 6:103-111.

 

42. Sadetzki S, Chetrit A, Freedman L, Stovall M, Modan B, Novikov I. Long-term

follow-up for brain tumor development following childhood exposure to

ionizing radiation for tinea capitis. Radiat Res 2005; 163: 424-432.

 

43. Muallem Kalmovich L, Elad D, Zaretsky U, Adunsky A, Chetrit A, Sadetzki

S, Segal S, Wolf M. Endonasal geometry changes in the elderly - acoustic

rhinometry measurements. J Gerontol A Biol Sci Med Sci 2005, 60: 396-8.

 

44. Sadetzki S, Flint-Richter P, Starinsky S, Novikov I, Lerman Y, Goldman B,

Friedman E. Genotyping of patients with sporadic and radiation-associated

meningiomas. Cancer Epidemiol Biomarkers Prev 2005; 14: 969-976.

 

45. Sadetzki S, Oberman B, Kaufman B, Riezel S, Novikov I, Zippel R, Papa M.

Breast conservation following neoadjuvant chemotherapy. Ann Surg Oncol

2005: 12: 1-8.

 

46. Grossman R, Sadetzki S, Spiegelmann R, Ram Z. Haemorrhagic

complications and the incidence of asymptomatic bleeding associated with

stereotactic brain biopsies. Acta Neurochir 2005; 147: 627-631.

 

47. Menczer J, Chetrit A, Barda J, Lubin F, Fishman A, Dgani R, Modan B,

Sadetzki S. Primary peritoneal carcinoma - uterine involvement and

hysterectomy. Gynecol Oncol 2006; 100: 565-9.

 

48. Wolf I, Sadetzki S, Kanety H, Kundel Y, Pariente C, Epstein N, Oberman B,

Catane R, Kaufman B, Shimon I. Adiponectin, ghrelin and leptin in cancer

cachexia in breast and colon cancer patients. Cancer 2006; 106:966-973.

 

49. Vrijheid M, Cardis E, Armstrong BK, Auvinen A, Berg G, Blaasaas KG,

Brown J, Carroll M, Chetrit A, Christensedn HC, Deltour I, Feychting M,

Giles GG, Hepworth SJ, Hours M, Iavarone I, Johansson C, Klaeboe L,

Kurttio P, Lagorio S, Lonn S, McKinney PA, Montestrucq L, Parslow RC,

Richardson L, Sadetzki S, Salmiinen T, Schuz J, Tynes T, Woodward A.

Validation of short-term recall of mobile phone use for the interphone study.

Occup Environ Med 2006;63:237-243.

 

50. Scope A, Sadetzki S, Sidi Y, Barzilai A, Trau H, Kaufman B, Catane R,

Ehrenfeld M. Breast cancer and scleroderma. Skinmed 2006; 5: 18-24.

 

51. Wolf I, Sadetzki S, Gluck I, Oberman B, Ben-David M, Papa MZ, Catane R,

Kaufman B. Association between diabetes mellitus and adverse

characteristics of breast cancer at presentation. Eur J Cancer 2006; 42:

1077-1082.

 

52. Sadetzki S, Flint-Richter P. Transgenerational effects of parental exposure to

ionizing radiation. Harefuah 2006; 145: 516-521.

 

53. Menczer J, Chetrit A, Sadetzki S, Golan A, Levy T. Follow-up of ovarian and

primary peritoneal carcinoma: The value of physical examination in patients

with pretreatment elevated ca125 levels. Gynecol Oncol 2006; 103: 137-140.

 

54. Symon Z, Kundel J, Sadetzki S, Oberman B, Ramon J, Catane R, Pfeffer R.

Radiation rescue for biochemical failure after surgery for prostate cancer:

predictive parameters and an assessment of contemporary predictive

models. Am J Clin Oncol 2006; 29: 446-450.

 

55. Lubina A, Cohen O, Barchana M, Liphshiz I, Vered I, Sadetzki S, Karasik A.

Time trends of incidence rates of thyroid cancer in Israel - what might explain

the sharp increase. Thyroid 2006; 16: 1033-1040.

 

56. Sadetzki S, Chetrit A, Lubina A, Stovall M, Novikov I. Risk of Thyroid Cancer

Following Childhood Exposure to Ionizing Radiation for Tinea Capitis. J Clin

Endocrin Metab 2006; 91: 4798-4804.

 

57. Yellin A, Sadetzki S, Simansky DA, Refaely Y, Chetrit A, Paley M. The

sequence of vessel interruption during lobectomy - does it affect the amount

of blood retained in the lobe? Eur J Cardiothorac Surg. 2007; 31: 711-713.

 

58. Flint-Richter P, Sadetzki S. Genetic predisposition for the development of

radiation associated meningioma: an epidemiological study. Lancet Oncol

2007; 8: 403-410.

 

59. Cardis E, Richardson L, Deltour I, Armstrong B, Feychting M, Johanssen C,

Kilkenny M, McKinney P, Modan B, Sadetzki S, Schüz J, Swerdlow A,

Vrijheid M, Auvinen A, Berg G, Blettner M, Bowman J, Brown J, Chetrit A,

Collatz CH, Cook A, Hepworth S, Giles G, Hours M, Iavarone I, Jarus-Hakak

A, Klaeboe L, Krewski D, Lagorio S, Lönn S, Mann S, McBride M, Muir K,

Nadon L, Parent M-E, Pearce N, Salminen T, Schoemaker M, Schlehofer B,

Siemiatycki J, Taki M, Takebayashi T, Tynes T, van Tongeren M, Vecchia P,

Wiart J, Woodward A, Yamaguchi N. The INTERPHONE Study: Design,

Epidemiological Methods, and Description of the Study Population. Eur J

Epidemiol. 2007; 22: 647-664.

 

60. Bader D, Datz H, Juster A, Marks K, Smolkin T, Zangen S, Kugelman A,

Hoffmann H, Shani G, Ben Shlomo A, Margaliot M, Sadetzki S.

Unintentional exposure of neonates to ionizing radiation during their stay in

the neonatal intensive care units. J Perinatol. 2007; 27: 579-585.

 

61. Malmer B, Adatto P, Armstrong G, Barnholtz-Sloan J, Bernstein J, Claus E,

Davis F, Houlston R, Il'yasova D, Jenkins R, Johansen C, Lai R, Lau C,

McCarthy B, Nielsen H, Olson S, Sadetzki S, Shete S, Wiklund F, Wrensch

M, Yang P, Bondy M. GLlOGENE - an international consortium to

understand familial glioma. Cancer Epidemiol Biomarkers Prev 2007; 16:

1730-1734.

 

62. Kundel Y, Sella A, Kovel S, Symon Z, Oberman B, Sadetzki S, Koller M ,

Catane R, Pfeffer R. A phase II study of oral UFT and leucovorin concurrently

with pelvic irradiation as neoadjuvant chemoradiation for rectal cancer.

Anticancer Res 2007; 27: 2877-80.

 

63. Kundel Y, Yellin A, Popovtzer A, Pfeffer R, Symon Z, Simansky DA,

Oberman B, Sadetzki S, Brenner B, Catane R, Levitt M. Adjuvant

radiotherapy for thymic epithelial tumor: treatment results and prognostic

factors. Am J Clin Oncol 2007; 30: 389-94.

 

64. Sadetzki S. Excess lifetime cancer mortality risk attributed to radiation

exposure from pediatric computed tomography scan (editorial). IMAJ 2007;

9: 607-609.

 

65. Sadetzki S, Chetrit A, Jarus-Hakak A, Cardis E, Deutch Y, Duvdevani S,

Zultan A, Novikov I, Freedman L, Wolf M. Cellular phone use and risk of

benign and malignant parotid gland tumors - a nationwide case-control study.

Am J Epidemiol 2008; 167: 457-467.

 

66. Chetrit A, Hirsh-Yechezkel G, Ben-David Y, Lubin F, Friedman E, Sadetzki

S, for the National Israeli Study of Ovarian Cancer. Effect of BRCA1/2

mutations on long-term survival of invasive ovarian cancer. J Clin Oncol 2008;

26: 20-25.

 

67. Collaborative Group in Epidemiological Studies of Ovarian Cancer. Ovarian

cancer and oral contraceptives: collaborative reanalysis of data from 45

epidemiological studies including 23257 women with ovarian cancer and

87303 controls. Lancet 2008; 371: 303-314.

 

68. Davis FG, Malmer BS, Aldape K, Barnholtz-Sloan JS, Bondy ML,

Brannstrom T, Bruner JM, Burger PC, Collins VP, Inskip PD, Kruchko C,

McCarthy BJ, McClendon RE, Sadetzki S, Tihan T, Wrensch MR, Buffler

PA. Issues of diagnostic review in brain tumor studies: from the brain tumor

epidemiology consortium. Cancer Epidemiol Biomarkers Prev 2008; 17: 484-

489.

 

69. Datz H, Ben-Shlomo A, Bader D, Sadetzki S, Juster-Reicher A, Marks K,

Smolkin T, Zangen S, Margaliot M. The additional dose to radiosensitive

organs caused by using under-collimated x-ray beams in neonatal intensive

care radiography. Radiat Prot Dosimetry 2008; 130: 518-524.

 

70. Sadetzki S, Oberman B, Mandelzweig L, Chetrit A, Ben-Tal T, Jarus-Hakak

A, Duvdevani S, Cardis E, Wolf M. Smoking and risk of parotid gland tumors-

A nationwide case-control study. Cancer 2008;112:1974-1982.

 

71. Papa MZ, Zippel D, Kaufman B, Shimon-Paluch S, Yosepovich A, Oberman

B, Sadetzki S. Timing of sentinel lymph node biopsy in patients receiving

Neoadjuvant chemotherapy for breast cancer. J Surg Oncol 2008; 98: 403-6.

 

72. Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il'yasova

D, Kruchko C, McCarthy BJ, Rajaraman P, Schwartzbaum JA, Sadetzki S,

Schlehofer B, Tihan T, Wiemels JL, Wrensch M, Buffler PA, on behalf of the

Brain Tumor Epidemiology Consortium. Brain tumor epidemiology:

consensus from the Brain Tumor Epidemiology Consortium. Cancer 2008;

113 (7 suppl): 1953-1968.

 

73. Sadetzki S, Zach L, Chetrit A, Nass D, Hoffmann C, Ram Z, Zaaroor M,

Umansky F, Rappaport ZH, Cohen A, Wald U, Rothman S, Hadani M.

Epidemiology of Gliomas in Israel: A Nationwide Study. Neuroepidemiology

2008; 31: 264-269.

 

74. Kundel Y, Levitt ML, Oberman B, Sadezki S, Tichler T, Symon Z, Catane R,

Pfeffer R, Brenner B. Adjuvant chemotherapy and whole abdominal irradiation

for gastric carcinoma. Tumori 2008; 94: 469-473.

 

75. Menczer J, Chetrit A, Sadetzki S, for the National Israel Ovarian Cancer

Group. The effect of symptom duration in epithelial ovarian cancer on

prognostic factors. Arch Gynecol Obstet 2009; 279: 797-801.

 

76. Vrijheid M, Richardson L, Armstrong BK, Auvinen A, Berg G, Carroll M,

Chetrit A, Deltour I, Feychting M, Giles GG, Hours M, Iavarone I, Lagorio S,

Lönn S, McBride M, Parent M-E, Sadetzki S, Salminen T, Sanchez M,

Schlehofer B, Schüz J, Siemiatycki J, Tynes T, Woodward A, Yamaguchi N,

Cardis E. Quantifying the impact of selection bias caused by non-

participation in a case-control study of mobile phone use. Ann Epidemiol

2009; 19: 33-42.

 

77. Sadetzki S, Mandelzweig L. Childhood exposure to external ionizing radiation

and cancer risk. Br J Cancer 2009; 100: 1021-1025.

 

78. Vrijheid M, Mann S, Vecchia P, Wiart J, Taki M, Ardoino L, Armstrong BK,

Auvinen A, Bédard D, Berg-Beckhoff G, Brown J, Chetrit A, Collatz-

Christensen H, Combalot E, Cook A, Deltour I, Feychting M, Giles GG,

Hepworth SJ, Hours M, Iavarone I, Johansen C, Krewski D, Kurttio P, Lagorio

S, Lönn S, McBride M, Montestrucq L, Parslow RC, Sadetzki S, Schüz J,

Tynes T, Woodward A, Cardis E. Determinants of mobile phone output power

in a multinational study - implications for exposure assessment. Occup

Environ Med 2009; 66: 664-671.

 

79. Efrati S, Sadetzki S, Zaretsky M, Kimiagar I, Rosenblum R, Marchaim D,

Berman S, Bar-Haim A, Abu Hamad R, Feigenzon M, Chetrit A, Yassky D,

Weissgarten J, Bass A. Carotid atherosclerotic disease following childhood

scalp irradiation. Atherosclerosis 2009; 204; 556-560.

 

80. Perri T, Korach J, Sadetzki S, Oberman B, Fridman E, Ben-Baruch G.

Uterine Leiomyosarcoma: does the primary surgical procedure matter? Int J

Gynecol Cancer 2009; 19: 257-260.

 

81. Mandelzweig L, Novikov I, Sadetzki S. Smoking and risk of glioma: a meta-

analysis. Cancer Causes Control 2009; 20: 1927-1938.

 

82. Menczer J, Chetrit A, Sadetzki S, for the National Israel Ovarian Cancer

Group. Ovarian carcinoma apparently confined to the ovaries - the accuracy of

surgical staging in Israel. Eur J Gynaecol Oncol 2009; 30: 375-378.

 

83. Freedman LS, Oberman B, Sadetzki S. Using time-dependent covariate

analysis to elucidate the relation of smoking history to Warthin's tumor risk.

Am J Epidemiol 2009; 170: 1178-1185.

 

84. Menczer J, Barchana M, Chetrit A, Liphshitz I, Sadetzki S. Incidence rates of

cervical carcinoma among first and second generation women of North

African origin in Israel. Int J Gynecol Cancer 2009; 19: 1606-1609.

 

85. Robertson LB, Armstrong GN, Olver BD, Lloyd AL, Shete S, Lau C, Claus

EB, Barnholtz-Sloan J, Lai R, Il'yasova D, Schildkraut J, Bernstein JL, Olson

SH, Jenkins RB, Yang P, Rynerason AL, Wrensch M, McCoy L, Wienkce

JK, McCarthy B, Davis F, Vick NA, Johansen C, Bødtcher H, Sadetzki S,

Bruchim RB, Yechezkel GH, Andersson U, Melin BS, Bondy ML, Houlston

RS. Survey of familial glioma and role of germline p16INK4A/p14ARF and

p53 mutation. Fam Cancer 2010; 9: 413-421.

 

86. Cardis E, Deltour I, Vrijheid M, Combalot E, Moissonnier M, Tardy H,

Armstrong B, Giles G, Brown J, Siemiatycki J, Parent ME, Nadon L;

Krewski D, McBride ML, Johansen C, Collatz Christensen H, Auvinen A,

Kurttio P, Lahkola A, Salminen T, Hours M, Bernard M, Montestruq L,

Schu¨z J, Berg-Beckhoff G, Schlehofer B, Blettner M, Sadetzki S, Chetrit A,

Jarus-Hakak A, Lagorio S, Iavarone I, Takebayashi T, Yamaguchi N,

Woodward A, Cook A, Pearce N, Tynes T, Blaasaas KG, Klaeboe L,

Feychting M, Lo¨nn S, Ahlbom A, McKinney PA, Hepworth SJ, Muir KR,

Swerdlow AJ, Schoemaker MJ. Brain tumour risk in relation to mobile

telephone use: results of the INTERPHONE international case-control study.

Int J Epidemiol 2010; 39: 675-694.

 

87. Shvarts S, Sevo G, Tasic M, Shani M, Sadetzki S. The Tinea Capitis

campaign in Serbia in the 1950s. Lancet Infect Dis 2010; 10: 571-76.

 

88. Menczer J, Chetrit A, Sadetzki S, The National Israel Ovarian Cancer

Group. Uterine metastases in ovarian carcinoma: frequency and survival in

women who underwent hysterectomy. J Gynecol Oncol 2010; 21:191-195.

 

89. Scheurer ME, Etzel CJ, Liu M, Barnholtz-Sloan J, Wiklund F, Tavelin B,

Wrensch MR, Melin BS, and Bondy ML for the GLIOGENE Consortium.

Familial aggregation of glioma: a pooled analysis. Am J Epidemiol 2010:

172: 1099-1107.

 

90. Paluch-Shimon S, Wolf I, Sadetzki S, Gluck I, Oberman B, Papa MZ, Catane

R, Kaufman B. Association between very young age and adverse

characteristics of breast cancer at presentation amongst Israeli women. Am

J Clin Oncol 2011; 34: 219-222.

 

91. Cardis E and Sadetzki S. Indications of possible brain tumour risk in mobile

phone studies - should we be concerned? Occup Environ Med 2011; 68: 169-

71.

 

92. Flint-Richter P, Mandelzweig L, Oberman B, Sadetzki S. Possible interaction

between ionizing radiation, smoking, and gender in the causation of

meningioma. Neuro-Oncol 2011; 13: 345-352.

 

93. Hosking FJ, Feldman D, Bruchim R, Olver B, Lloyd A, Vijayakrishnan J,

Flint-Richter P, Broderick P, Houlston RS, Sadetzki S. Search for inherited

susceptibility to radiation associated meningioma by genomewide SNP

linkage-disequilibrium mapping. Br J Cancer 2011; 104: 1049-1054.

 

94. Sagi OI, Sadetzki S. Determining health policy for sensible mobile phone use

- current world status. Harefuah 2011; 150: 216-221.

 

95. Cardis E, Armstrong BK, Bowman JD, Giles GG, Hours M, Krewski D,

McBride M, Parent M-E, Sadetzki S, Woodward A, Brown J, Chetrit A,

Figuerola J, Hoffman C, Jarus Hakak A, Montestruq L, Nadon L, Richardson

L, Villegas R, Verijheid M. Risk of brain tumours in relation to estimated RF

dose from mobile phones: results from five Interphone countries. Occup

Environ Med 2011; 68: 631-640.

 

96. Cardis E, Deltour I, Verijheid M, Evrard AS, Sanchez M, Moissonnier M,

Armstrong B, Brown J, Giles G, Siemiatycki J, Nadon L, Parent ME,

Krewski D, McBride MM, Johansen C, Christensen HC, Auvinen A, Kurttio

P, Lahkola A, Salminen T, Hours M, Bernard M, Montestruq L, Schuz J,

Blettner M, Berg-Beckhoff G, Schlehofer B, Sadetzki S, Chetrit A, Jarus-

Hakak J, Lagorio S, Iavarone I, Takebayashi T, Yamaguchi N, Woodward A,

Cook A, Pearce N, Tynes T, Klaeboe L, Blaasaas KG, Feychting M, Lonn S,

Ahlbom A, McKinney PA, Hepworth SJ, Muir KR, Swerdlow AJ, Schoemaker

MJ. Acoustic neuroma risk in relation to mobile telephone use: results of the

INTERPHONE International case-control study. Cancer Epidemiol 2011; 35:

453-464.

 

97. Sadetzki S, Chetrit A, Mandelzweig L, Nahon D, Freedman L, Susser E,

Gross R. Childhood exposure to ionizing radiation to the head and risk of

schizophrenia. Radiat Res 2011; 176: 670-677.

 

98. Shete S, Lau CC, Houlston RS, Claus EB, Barnholtz-Sloan J, Lai R, Il'yasova

D, Schildkraut J, Sadetzki S, Johansen C, Bernstein JL, Olson SH, Jenkins

RB, Yang P, Vick NA, Wrensch M, Davis FG, McCarthy BJ, Leung EH,

Davis C, Cheng R, Hosking FJ, Armstrong GN, Liu Y, Yu RK, Henriksson R;

Gliogene Consortium, Melin BS, Bondy ML. Genome-wide high-density SNP

linkage search for glioma susceptibility loci: results from the Gliogene

Consortium. Cancer Res 2011; 71: 7568-7575.

 

99. Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ, Karlan BY,

Lambrechts D, Despierre E, Barrowdale D, McGuffog L, Healey S, Easton

DF, Sinilnikova O, Benítez J, García M, Neuhausen S, Gail MH, Hartge P,

EMBRACE study team, Peock S, Frost D, Evans DG, Eeles R, Godwin AK,

Daly MB, Kwong A, Ma ESK, Lázaro C, Blanco I, Montagna M, D'Andrea E,

Nicoletto O, kConFab Investigators, Johnatty SE, Krüger Kjær S, Jensen A,

Høgdall E, Goode EL, Fridley BL, Loud JT, Greene MH, Mai PL, Chetrit A,

Lubin F, Hirsh-Yechezkel G, Glendon G, Andrulis IL, Toland AE, Senter L,

Gore ME, Gourley C, Michie CO, Song H, Tyrer J, Whittemore AS, McGuire

V, Sieh W, Kristoffersson U, Olsson H, Borg A, Levine DA, Cancer Genome

Atlas Research Network, Steele L, Beattie MS, Chan S, Nussbaum R,

Moysich KB, Gross J, Cass I, Walsh C, Li AJ, Leuchter R, Gordon O,

Garcia-Closas M, Gayther SA, Chanock SJ, Antoniou AC, Pharoah PDP.

Association between BRCA1 and BRCA2 mutations and survival in women

with invasive epithelial ovarian cancer. JAMA 2012; 307: 382-390.

 

100. Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian

cancer and body size: individual participant meta-analysis including 25,157

women with ovarian cancer from 47 epidemiological studies. PLoS Med

2012; 9 (4):e1001200.

 

101. Menczer J, Chetrit A, Sadetzki S and for the National Israel Ovarian Cancer

Group. The effect of hysterectomy on survival of patients with borderline

ovarian tumors. Gynecol Oncol 2012; 125: 372-5.

 

102. Liu Y, Melin BS, Rajaraman P, Wang Z, Linet M, Shete S, Amos CI, Lau

CC, Scheurer ME, Tsavachidis S, Armstrong GN, Houlston RS, Hosking FJ,

Claus EB, Barnholtz-Sloan J, Lai R, Il'yasova D, Schildkraut J, Sadetzki S,

Johansen C, Bernstein JL, Olson SH, Jenkins RB, Lachance D, Vick NA,

Wrensch M, Davis F, McCarthy BJ, Andersson U, Thompson PA, Chanock

S; The Gliogene Consortium, Bondy ML. Insight in glioma susceptibility

through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP

genotypes in familial and non-familial glioma. Hum Genet 2012; 131: 1507-

17.

 

103. Azizi E, Pavlotsky F, Kudish A, Flint P, Solomon A, Lerman Y, Oberman B,

Sadetzki S. Serum levels of 25-Hydroxy-Vitamin D3 among sun-protected

outdoor workers in Israel. Photochem Photobiol 2012; 88: 1507-1512.

 

104. Veiga LH, Lubin JH, Anderson H, de Vathaire F, Tucker M, Bhatti P,

Schneider A, Johansson R, Inskip P, Kleinerman R, Shore R, Pottern L,

Holmberg E, Hawkins MM, Adams MJ, Sadetzki S, Lundell M, Sakata R,

Damber L, Neta G, Ron E. A pooled analysis of thyroid cancer incidence

following radiotherapy for childhood cancer. Radiat Res 2012; 178: 365-376.

 

105. Lidar M, Yonath H, Shechter N, Sikron F, Sadetzki S, Langevitz P, Livneh

A, Pras E. Incomplete response to colchicine in M694V homozygote FMF

patients. Autoimmun Rev 2012; 12: 72-6.

 

106. Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian

cancer and smoking: individual participant meta-analysis including 28,114

women with ovarian cancer from 51 epidemiological studies. Lancet Oncol

2012; 13: 946-956.

 

107. Sun X, Vengoechea J, Elston R, Chen Y, Amos C, Armstrong G, Bernstein

J, Claus E, Davis F, Houlston R, Il'yasova D, Jenkins R, Johansen C, Lai R,

Lau C, Liu Y, McCarthy B, Olson S, Sadetzki S, Schildkraut J, Shete S, Yu

R, Vick N, Merrell R, Wrensch M, Yang P, Melin B, Bondy M, Barnholtz-

Sloan J. A variable age of onset segregation model for linkage analysis with

correction for ascertainment applied to glioma. Cancer Epidemiol

Biomarkers Prev 2012; 21: 2242-2251.

 

108. Shimoni A, Shem-Tov N, Chetrit A, Volchek Y, Tallis E, Avigdor A, Sadetzki

S, Yerushalmi R, Nagler A. Secondary malignancies after allogeneic stem-

cell transplantation in the era of reduced-intensity conditioning; the

incidence is not reduced. Leukemia 2013 ; 27: 829-35.

 

109. Sadetzki S, Bruchim R, Oberman B, Armstrong GN, Lau CC, Claus EB,

Barnholtz-Sloan JS, Il'yasova D, Schildkraut J, Johansen C, Houlston RS,

Shete S, Amos CI, Bernstein JL, Olson SH, Jenkins RB, Lachance D, Vick

NA, Merrell R, Wrensch M, Davis FG, McCarthy BJ, Lai R, Melin BS,

Bondy ML; Gliogene Consortium. Description of selected characteristics of

familial glioma patients - Results from the Gliogene Consortium. Eur J

Cancer 2013; 49: 1335-1345.

 

110. Turner MC, Krewski D, Armstrong B, Chetrit A, Giles G, Hours M, McBride

ML, Parent M-E, Sadetzki S, Siemiatycki J, Woodward A, Cardis E.

Allergy and Brain Tumors in the INTERPHONE study: Pooled Results from

Australia, Canada, France, Israel, and New Zealand. Cancer Causes

Control 2013; 24: 949-60.

 

111. Halshtok Neiman O, Sadetzki S, Chetrit A, Raskin S, Yaniv G, Hoffmann C.

Perfusion-weighted imaging of peritumoral edema can help in the differential

diagnosis of glioblastoma mulltiforme versus brain metastasis. Isr Med

Assoc J 2013; 15: 103-5.

 

112. van Tongeren M, Kincl L, Richardson L, Benke G, Figuerola J, Kauppinen T,

Lakhani R, Lavoué J, McLean D, Plato N, Cardis E, INTEROCC Study

Group. Assessing occupational exposure to chemicals in an international

epidemiological study of brain tumours. Ann Occup Hyg 2013; 57: 610-26.

 

113. Rotenstreich Y, Belkin M, Sadetzki S, Chetrit A, Ferman-Attar G, Harari A,

Shaish A, Harats D. Treatment with 9-cis β-Carotene-rich powder in patients

with retinitis pigmentosa. JAMA Ophthalmol 2013; 131: 985-992.

 

114. Lacourt A, Cardis E, Pintos J, Richardson L, Kincl L, Benke G, Fleming S,

Hours M, Krewski D, McLean D, Parent ME, Sadetzki S, Schlaefer K,

Schlehofer B, Lavoue J, Van Tongeren M, Siemiatycki J. INTEROCC case-

control study: lack of association between glioma tumors and occupational

exposure to selected combustion products, dusts and other chemical

agents. BMC Public Health 2013; 13: 340.

 

115. Sadot E, Wasserberg N, Shapiro R, Keidar A, Oberman B, Sadetzki S.

Acute Appendicitis in the 21st century: should we modify the management

protocol? J Gastrointest Surg. 2013; 17: 1462-1470.

 

116. Gabbay U, Leshukovits Y, Sadetzki S. Immigrants' mortality patterns in the

short - and long-term point toward origin related diversities: the Israeli

experience. J Immigr Minor Health 2014; 16: 35-43.

 

117. McLean D, Fleming S, Turner MC, Kincl L, Richardson L, Benke G,

Schlehofer B, Schlaefer K, Parent ME, Hours M, Krewski D, van Tongeren

M, Sadetzki S, Siemiatycki J, Cardis E. Occupational solvent exposure and

risk of meningioma: results from the INTEROCC multicentre case-control

study. Occup Environ Med 2014; 71: 253-8.

 

118. Andersson U, Wibom C, Cederquist K, Aradottir S, Borg Å, Armstrong GN,

Shete S, Lau CC, Bainbridge MN, Claus EB, Barnholtz-Sloan J, Lai R,

Il'yasova D, Houlston RS, Schildkraut J, Bernstein JL, Olson SH, Jenkins

RB, Lachance DH, Wrensch M, Davis FG, Merrell R, Johansen C, Sadetzki

S, The Gliogene Consortium, Bondy ML, Melin BS. Germline

rearrangements in families with strong family history of glioma and

malignant melanoma, colon and breast cancer. Neuro Oncol 2014; 16:

1333-1340.

 

119. Ben-Ami E, Merom H, Sikron F, Livneh J, Sadetzki S, Wolf I. Involvement of

the family physician in the care of the chemotherapy-treated patients with

cancer: patients' perspectives. J Oncol Pract 2014; 10: 298-305.

 

120. Turner MC, Benke G, Bowman J, Figuerola J, Fleming S, Hours M, Kincl L,

Krewski D, Lavoue J, McLean D, Parent ME, Richardson L, Sadetzki S,

Schlaefer K, Schlehofer B, Siemiatycki J, van Tongeren M, Cardis E.

Occupational exposure to extremely low frequency magnetic fields and

brain tumour risks in the INTEROCC study. Cancer Epidemiol

Biomarkers Prev 2014; 23: 1863-1872.

 

121. Sadetzki S, Langer CE, Bruchim R, Kundi M, Merletti F, Vermeulen R,

Kromhout H, Lee AK, Maslanyj M, Sim MR, Taki M, Wiart J, Armstrong B,

Milne E, Benke G, Schattner R, Hutter HP, Woehrer A, Krewski D, Mohipp

C, Momoli F, Ritvo P, Spinelli J, Lacour B, Delmas D, Remen T, Radon K,

Weinmann T, Klostermann S, Heinrich S, Petridou E, Bouka E,

Panagopoulou P, Dikshit R, Nagrani R, Even-Nir H, Chetrit A, Maule M,

Migliore E, Filippini G, Miligi L, Mattioli S, Yamaguchi N, Kojimahara N, Ha

M, Choi KH, Mannetje A, Eng A, Woodward A, Carretero G, Alguacil J,

Aragones N, Suare-Varela MM, Goedhart G, Schouten-van Meeteren AA,

Reedijk AA, Cardis E. The MOBI-Kids Study Protocol: challenges in

assessing childhood and adolescent exposure to electromagnetic fields

from wireless telecommunication technologies and possible association with

brain tumor risk. Front Public Health 2014 Sep 23; 2: 124.

 

122. Bainbridge MN, Armstrong GN, Gramatges MM, Bertuch AA, Jhangiani SN,

Doddapaneni H, Lewis L, Tombrello J, Tsavachidis S, Liu Y, Jalali A, Plon

SE, Lau CC, Parsons DW, Claus EB, Barnholtz-Sloan J, Il'yasova D,

Schildkraut J, Ali-Osman F, Sadetzki S, Johansen C, Houlston RS,

Jenkins RB, Lachance D, Olson SH, Bernstein JL, Merrell RT, Wrensch

MR, Walsh KM, Davis FG, Lai R, Shete S, Aldape K, Amos CI, Thompson

PA, Muzny DM, Gibbs RA, Melin BS, Bondy ML; Gliogene Consortium.

Germline mutations in shelterin complex genes are associated with familial

glioma. J Natl Cancer Inst 2014; 107: 384.

 

123. Candido-dos-Reis FJ, Song H, Goode EL, Cunningham JM, Fridley BL,

Larson M, Alsop K, Dicks E, Harrington P, Ramus SJ, DeFazio A, Mitchell

G, Fereday S, Bolton KL, Gourley C, Michie C, Karlan B, Lester J, Walsh

C, Cass I, Olsson HL, Gore ME, Benitez J, García MJ, Andrulis I, Mulligan

AM, Glendon G, Blanco I, Lazaro C, Whittemore AC, McGuire V, Sieh W,

Montagna M, Alducci E, Sadetzki S, Chetrit A, Kwong A, Kjaer SK, Jensen

A, Høgdall E, Neuhausen S, Nussbaum R, Daly MB, Greene MH, Mai PL,

Loud JT, Moysich K, Toland AE, Lambrechts D, Ellis S, Frost D, Brenton

JD, Tischkowitz M, Easton DF, Antoniou A, Chenevix-Trench G, Gayther

SA, Bowtell DD, and Pharoah PDP. Germline mutation in BRCA1 or

BRCA2 and ten-year survival for women diagnosed with epithelial ovarian

cancer. Clin Cancer Res 2015; 21: 652-657.

 

124. Collaborative Group on Epidemiological Studies of Ovarian Cancer.

Menopausal hormone use and ovarian cancer risk: individual participant

meta-analysis of 52 epidemiological studies. Lancet 2015; 385: 1835-42.

 

125. Jalali A, Amirian ES, Bainbridge MN, Armstrong GN, Liu Y, Tsavachidis S,

Jhangiani SN, Plon SE, Lau CC, Claus EB, Barnholtz-Sloan JS, Il'yasova D,

Schildkraut J, Ali-Osman F, Sadetzki S, Johansen C, Houlston RS, Jenkins

RB, Lachance D, Olson SH, Bernstein JL, Merrell RT, Wrensch MR, Davis

FG, Lai R, Shete S, Aldape K, Amos CI, Muzny DM, Gibbs RA, Melin BS,

Bondy ML. Targeted sequencing in chromosome 17q linkage region

identifies familial glioma candidates in the Gliogene Consortium. Sci Rep

2015 Feb 5; 5: 8278.

 

126. Perri T, Lifshitz D, Sadetzki S, Oberman B, Meirow D, Ben-Baruch G;

Fridman E; Korach J. Fertility treatments and invasive epithelial ovarian

cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers. Fertil Steril

2015; 103: 1305-1312.

 

127. Collaborative Group on Epidemiological Studies on Endometrial Cancer.

Endometrial cancer and oral contraceptives: an individual participant meta-

analysis of 27 276 women with endometrial cancer from 36 epidemiological

studies. Lancet Oncol 2015; 16: 1061-1070.

 

128. Vered Y, Chetrit A, Amitai T, Sgan-Cohen H, Mann J, Even-Nir H, Sadetzki

S. Long term effects of exposure to ionizing irradiation on periodontal health

status - The Tinea Capitis Cohort Study. Front Public Health 2015 Oct 19;

3: 226.

 

129. Vila J, Bowman JD, Richardson L, Kincl L, Conover DL, McLean D, Mann S,

Vecchia P, van Tongeren M, Cardis E, on behalf of the INTEROCC Study

Group. A source-based measurement database for occupational exposure

assessment of electromagnetic fields in the INTEROCC study: A literature

review approach. Ann Occup Hyg 2016; 60: 184-204.

 

130. Amirian ES, Armstrong GN, Zhou R, Lau CC, Claus EB, Barnholtz-Sloan

JS, Il'yasova D, Schildkraut J, Ali-Osman F, Sadetzki S, Johansen C,

Houlston RS, Jenkins RB, Lachance D, Olson SH, Bernstein JL, Merrell RT,

Wrensch MR, Davis FG, Lai R, Shete S, Amos CI, Scheurer ME, Aldape K,

Alafuzoff I, Brännström T, Broholm H, Collins P, Giannini C, Rosenblum M,

Tihan T, Melin BS, and Bondy ML. The glioma international case-control

study: a report from the genetic epidemiology of glioma international

consortium. Am J Epidemiol 2016; 183: 85-91.

 

131. Mandelzweig L, Chetrit A, Amitai T, Oberman B, Siegelmann Danieli N,

Silverman B, Sadetzki S. Identification of health care needs of long-term

breast cancer survivors among Israeli women. Support Care Cancer 2016;

24: 737-46.

 

132. Amirian ES, Zhou R, Wrensch MR, Olson SH, Scheurer ME, Il'yasova D,

Lachance D, Armstrong GN, McCoy LS, Lau CC, Claus EB, Barnholtz-

Sloan JS, Schildkraut J, Ali-Osman F, Sadetzki S, Johansen C, Houlston

RS, Jenkins RB, Bernstein JL, Merrell RT, Davis FG, Lai R, Shete S, Amos

CI, Melin BS, and Bondy ML. Approaching a Scientific Consensus on the

Association between Allergies and Glioma Risk: A Report from the Glioma

International Case-Control Study. Cancer Epidemiol Biomarkers Prev 2016;

25: 282-290.

 

133. Vered Y, Chetrit A, Amitai T, Sgan-Cohen H, Mann J, Even-Nir H, Sadetzki

S. Caries experience among adults exposed to low to moderate doses of

ionizing radiation in childhood - the Tinea Capitis cohort. Front Public

Health 2016 Feb 23; 4: 18.

 

134. Amirian ES, Scheurer M, Zhou R, Wrensch M, Armstrong GN, Lachance D,

Olson SH, Lau CC, Claus EB, Barnholtz-Sloan JS, Il'yasova D, Schildkraut

J, Ali-Osman F, Sadetzki S, Jenkins RB, Bernstein JL, Merrell RT, Davis

FG, Lai R, Shete S, Amos CI, Melin BS, Bondy ML. History of chickenpox

in glioma risk: a report from the glioma international case-control study

(GICC). Cancer Med 2016; 5: 1352-8.

 

135. Veiga LHS, Holmberg E, Anderson H, Pottern L, Sadetzki S, MJ Adams,

Sakata R, Schneider AB, Inskip P, Bhatti P, Johansson R, Neta G, Shore

R, de Vathaire F, Damber L, Kleinerman R, Hawkins MM, Tucker M, Lundell

M, Lubin JH. Thyroid cancer after childhood exposure to external radiation:

an updated pooled analysis of 12 studies. Radiat Res 2016; 185: 473-484.

 

136. Wang Y, Bernhardy AJ, Cruz C, Krais JJ, Nacson J, Nicolas E, Peri S, van

der Gulden H, van der Heijden I, O'Brien SW, Zhang Y, Harrell MI, Johnson

SF, Candido Dos Reis FJ, Pharoah PD, Karlan B, Gourley C, Lambrechts

D, Chenevix-Trench G, Olsson H, Benitez JJ, Greene MH, Gore M,

Nussbaum R, Sadetzki S, Gayther SA, Kjaer SK; kConFab Investigators,

D'Andrea AD, Shapiro GI, Wiest DL, Connolly DC, Daly MB, Swisher EM,

Bouwman P, Jonkers J, Balmaña J, Serra V, Johnson N. The BRCA1-Δ11q

alternative splice isoform bypasses germline mutations and promotes

therapeutic resistance to PARP inhibition and cisplatin. Cancer Res 2016;

76: 2778-90.

 

137. Sadetzki S, Chetrit A, Turner MC, van Tongeren M, Benke G, Figuerola J,

Fleming S, Hours M, Kincl L, Krewski D, McLean D, Parent ME,

Richardson L, Schlehofer B, Schlaefer K, Blettner M, Schüz J, Siemiatycki

J, Cardis E. Occupational exposure to metals and risk for meningioma - a

multinational case-control study. J Neurooncol 2016; 130: 505-515.

 

138. Grell K, Frederiksen K, Schüz J, Cardis E, Armstrong B, Siemiatycki J,

Krewski DR, McBride ML, Johansen C, Auvinen A, Hours M, Blettner M,

Sadetzki S, Lagorio S, Yamaguchi N, Woodward A, Tynes T, Feychting M,

Fleming SJ, Swerdlow AJ, Andersen PK. The intracranial distribution of

gliomas in relation to exposure from mobile phones: analyses from the

Interphone Study. Am J Epidemiol 2016; 184: 818-828.

 

139. Turner MC, Sadetzki S, Langer CE, Villegas R, Figuerola J, Armstrong BK,

Chetrit A, Giles GG, Krewski D, Hours M, McBride ML, Parent ME,

Richardson L, Siemiatycki J, Woodward A, Cardis E. Investigation of bias

related to differences between case and control interview dates in five

INTERPHONE countries. Ann Epidemiol 2016; 26: 827-832.

 

140. Mandelzweig L, Chetrit A, Amitai T, Silverman B, Siegelmann- Danieli N,

Sadetzki S. Primary prevention and screening practices among long-

term breast cancer survivors Cancer Causes Control 2017; 28: 657-666.

 

141. Turner MC, Benke G, Bowman JD, Figuerola J, Fleming S, Hours M, Kincl L, Krewski D, McLean D, Parent ME, Richardson L, Sadetzki S, Schlaefer K, Schlehofer B, Schüz J, Siemiatycki J, Tongeren MV, Cardis E. Interactions between occupational exposure to extremely low frequency magnetic fields and chemicals for brain tumor risk in the INTEROCC study. Occup Environ Med 2017; 74: 802-809.

 

142. Langer CE, de Llobet P, Dalmau A, Wiart J, Goedhart G, Hours M, Benke GP, Bouka E, Bruchim R, Choi KH, Eng A, Ha M, Karalexi M, Kiyohara K, Kojimahara N, Krewski D, Kromhout H, Lacour B, 't Mannetje A, Maule M, Migliore E, Mohipp C, Momoli F, Petridou E, Radon K, Remen T, Sadetzki S, Sim MR, Weinmann T, Vermeulen R, Cardis E, Vrijheid M. Patterns of cellular phone use among young people in 12 countries: Implications for RF exposure. Environ Int 2017; 107: 65-74.

 

143. Sadetzki S, Chetrit A, Freedman LS, Hakak N, Barchana M, Catane R, Shani M. Cancer Risk among Holocaust Survivors in Israel - A Nationwide Study. Cancer 2017; 123: 3335-33345.

 

144. Parent ME, Turner MC, Lavoué J, Richard H, Figuerola J, Kincl L, Richardson L, Benke G, Blettner M, Fleming S, Hours M, Krewski D, McLean D, Sadetzki S, Schlaefer K, Schlehofer B, Schüz J, Siemiatycki J, van Tongeren M, Cardis E. Lifetime occupational exposure to metals and welding fumes, and risk of glioma: a 7-country population-based case-control study. Environ Health 2017 Aug 25; 16: 90.

 

145. Benke G, Turner MC, Fleming S, Figuerola J, Kincl L, Richardson L, Blettner M, Hours M, Krewski D, McLean D, Parent ME, Sadetzki S, Schlaefer K, Schlehofer B, Siemiatycki J, van Tongeren M, Cardis E. Occupational solvent exposure and risk of glioma in the INTEROCC study. Br J Cancer 2017; 117:

1246-1254.

 

146. McElvenny DM, van Tongeren M, Turner MC, Benke G, Figuerola J, Fleming S, Hours M, Kincl L, Krewski D, McLean D, Parent M-E, Richardson L, Schlehofer B, Schlaefer K, Sadetzki S, Schüz J, Siemiatycki J, Cardis E. The INTEROCC case-control study: Risk of meningioma and occupational exposure to selected combustion products, dusts and other chemical agents. Occup Environ Med 2018; 75: 12-22.

 

147. Dankner R, Gabbay U, Leibovici L, Sadeh M, Sadetzki S. Implementation of a competency-based medical education approach in public health and epidemiology training of medical students. Isr J Health Policy Res 2018; 7: 13.

 

148. Berntsson SG, Merrell RT, Amirian ES, Armstrong GN, Lachance D, Smits A, Zhou R, Jacobs DI, Wrensch MR, Olson SH, Il'yasova D, Claus EB, Barnholtz-Sloan JS, Schildkraut J, Sadetzki S, Johansen C, Houlston RS, Jenkins RB, Bernstein JL, Lai R, Shete S, Amos CI, Bondy ML, Melin BS. Glioma-related seizures in relation to histopathological subtypes: a report from the glioma international case-control study. J Neurol 2018 ;265: 1432-1442.

 

149. Goedhart G, van Wel L, Langer CE, de Llobet Viladoms P, Wiart J, Hours M, Kromhout H, Benke G, Bouka E, Bruchim R, Choi KH, Eng A, Ha M, Huss A, Kiyohara K, Kojimahara N, Krewski D, Lacour B, 't Mannetje A, Maule M, Migliore E, Mohipp C, Momoli F, Petridou ET, Radon K, Remen T, Sadetzki S, Sim M, Weinmann T, Cardis E, Vrijheid M, Vermeulen R. Recall of mobile phone usage and laterality in young people: The multinational Mobi-Expo study. Environ Res 2018; 165: 150-157.

 

150. Ostrom Q, Kinnersley B, Wrensch M, Eckel-Passow JE, Armstrong G, Rice T, Chen Y, Wiencke JK, McCoy LS, Hansen HM, Amos CI, Bernstein JL, Claus EB, Il'yasova D, Johansen C, Lachance DH, Lai RK, Merrell RT, Olson SH, Sadetzki S, Schildkraut JM, Shete S, Rubin JB, Lathia JD, Berens ME, Andersson U, Rajaraman P, Chanock SJ, Linet MS, Wang Z, Yeager M, GliomaScan consortium, Houlston RS, Jenkins RB, Melin B, Bondy ML, Barnholtz-Sloan JS. Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21. Sci Rep 2018; 8: 7352.

 

151. Vila J, Turner MC, Gracia-Lavedan E, Figuerola J, Bowman JD, Kincl L, Richardson L, Benke G, Hours M, Krewski D, McLean D, Parent ME, Sadetzki S, Schlaefer K, Schlehofer B, Schüz J, Siemiatycki J, van Tongeren M, Cardis E, INTEROCC Study Group. Occupational exposure to high-frequency electromagnetic fields and brain tumor risk in the INTEROCC study: An individualized assessment approach. Environ Int 2018; 119: 353-365.

 

152. Little MP, Wakeford R, Borrego D, French B, Zablotska LB, Adams MJ, Allodji R, de Vathaire F, Lee C, Brenner AV, Miller JS, Campbell D, Pearce MS, Doody MM, Holmberg E, Lundell M, Sadetzki S, Linet MS, Berrington de González A. Leukaemia and myeloid malignancy among people exposed to low doses (<100 mSv) of ionising radiation during childhood: a pooled analysis of nine historical cohorts studies. Lancet Haematol 2018; 5: e346-e358.

 

153. Ostrom QT, Coleman W, Huang W, Rubin JB, Lathia JD, Berens ME, Speyer G, Liao P, Wrensch MR, Eckel-Passow JE, Armstrong G, Rice T, Wiencke JK, McCoy LS, Hansen HM, Amos CI, Bernstein JL, Claus EB, Houlston RS, Il'yasova D, Jenkins RB, Johansen C, Lachance DH, Lai RK, Merrell RT, Olson SH, Sadetzki S, Schildkraut JM, Shete S, Andersson U, Rajaraman P, Chanock SJ, Linet MS, Wang Z, Yeager M; GliomaScan consortium, Melin B, Bondy ML, Barnholtz-Sloan JS. Sex-specific gene and pathway modeling of inherited glioma risk. Neuro Oncol 2018 Aug 14.

 

154. Ostrom QT, Kinnersley B, Armstrong G, Rice T, Chen Y, Wiencke JK, McCoy LS, Hansen HM, Amos CI, Bernstein JL, Claus EB, Eckel-Passow JE, Il'yasova D, Johansen C, Lachance DH, Lai RK, Merrell RT, Olson SH, Sadetzki S, Schildkraut JM, Shete S, Rubin JB, Andersson U, Rajaraman P, Chanock SJ, Linet MS, Wang Z, Yeager M; GliomaScan consortium, Houlston RS, Jenkins RB, Wrensch MR, Melin B, Bondy ML, Barnholtz-Sloan JS. Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age. Int J Cancer 2018; 143: 2359-2366.

 

155. Deltour I, Schlehofer B, Klaus S, Massardier-Pilonchéry A, Armstrong B, Giles G, Siemiatycki J, Parent ME, Krewski D, Mc Bride M, Johansen C, Christensen HC, Auvinen A, Salminen T, Hours M, Blettner M, Berg G, Sadetzki S, Chetrit A, Lagorio S, Iavarone I, Yamaguchi N, Takebayashi T, Tynes T, Klaeboe L, Woodward A, Cook A, Feychting M, Lonn S, Swerdlow T, Schoemaker M, Mc Kinney T, Fleming S, Moissonnier M, Kesminiene A, Cardis E, Schüz J. Exposure to loud noise and risk of acoustic neuroma: results from the INTERPHONE international case-control study. Scand J Work Environ Health 2018 November 5.

 

156. Turner MC, Gracia-Lavedan E, Momoli F, Langer CE, Castaño-Vinyals G, Kundi M, Maule M, Merletti F, Sadetzki S, Vermeulen R, Albert A, Alguacil J, Aragones N, Badia F, Bruchim R, Carretero G, Kojimahara N, Lacour B, Morales-Suarez-Varela M, Radon K, Remen T, Weinmann T, Yamaguchi N, Cardis E. Nonparticipation Selection Bias in the MOBI-Kids Study. Epidemiology 2019; 30: 145-153.

 

Chapters in books

1. Papa MZ & Sadetzki S. Regional Breast Cancer Treatment. In: Schlag PM,

Stein U, eds. Regional Cancer Therapy. Totowa, NJ: Humana Press, 2007 (p.

313-328).

 

2. Sadetzki S. (2007). Cancer Epidemiology. In: Y. Shoenfeld, Y Shemer and G.

Keren, eds. The Israeli Medical Encyclopedia. Tel-Aviv: Yediot books

publication (Vol. 7, p. 1558-1560).

 

3. Sadetzki S. Responsibility and accountability in preventive medicine - are we

doing too much or too little? In: Rosen B, Israeli A and Shortell S, ed.

Improving health and health care - who is responsible? Who is a countable?

Ramat Gan: The Israel National Institute for Health Policy Research, 2010 (p.

76-86).

 

4. Umansky F, Sadetzki S, Spektor S, Rosenthal G, Fraifeld S, Shoshan Y.

Radiation-Induced Meningiomas. In: Pamir MN, Black P, Falbusch R, eds.

Meningiomas: A Comprehensive Text. Philadelphia, PA: Elsevier, Inc., 2010.

(p. 79-97).

 

5. Il'yasova D, Davis F, Lai R, Dolecek T, Sadetzki S. Chemical exposures

mediated through occupation, environment and Lifestyle, and brain tumor risk.

In: Mehta MP, Chang S, Newton H, Guha A, Vogelbaum M, eds. Principles

and Practice of Neuro-Oncology: A Multidisciplinary Approach. New York:

Demos Medical Publishing, 2011 (p. 18-25).

 

6. Sadetzki S, Mandelzweig L. Exposure to ionizing radiation and glioma risk. In:

Mehta MP, Chang S, Newton H, Guha A, Vogelbaum M, eds. Principles and

Practice of Neuro-Oncology: A Multidisciplinary Approach. New York: Demos

Medical Publishing, 2011 (p. 26-30).

 

7. Sadetzki S. Responsibility and accountability in preventive medicine - are we

doing too much or too little? In: Rosen B, Israeli A and Shortell S, eds.

Accountability and responsibility in health care: issues in addressing an

emerging global challenge. World scientific series in global healthcare

economics and public policy - Vol. 1. Hackensack, NJ: World Scientific

Publishing, 2012 (p.219-231).

 

8. Perry A, Louis DN, Budka H, von Deimling A, Sahm F, Rushing EJ, Mawrin C,

Claus EB, Loeffler J, Sadetzki S. Meningioma. In: Louis DN, Ohgaki H,

Wiestler OD, Cavenee WK, eds. WHO classification of tumors of the central

nervous system. 4th ed. IARC Press, Lyon, 2016 (p. 232-237).

 

9. Shvarts S, Goran S, Tasik M, Shani M, Sadetzki S. UNICEF and the journey to

exterminate the Tinea Capitis in Yugoslavia (Serbia) during the 50's of the 20th century. In: Shvarts S & Sadetzki S (Eds.). Ringworm. Historical, Medical and Social Aspects of its Treatment. Beer Sheva: Ben Gurion University, 2018 (p289-319).

 

10. Sadetzki S. Tinea Capitis Research in Israel - Part I (1965-1995) - think before you act. In: Shvarts S & Sadetzki S (Eds.). Ringworm. Historical, Medical and Social Aspects of its Treatment. Beer Sheva: Ben Gurion University, 2018 (p289-319).

 

11. Sadetzki S. Tinea Capitis research in Israel - Part II (1995-2007): from risk assessment to genetic epidemiology - "Sadetzki's files". In: Shvarts S & Sadetzki S (Eds.). Ringworm. Historical, Medical and Social Aspects of its Treatment. Beer Sheva: Ben Gurion University, 2018 (p. 321-355).

 

12. Sadetzki S. From research to legislation and formulation of health policy. In: Shvarts S & Sadetzki S (Eds.). Ringworm. Historical, Medical and Social Aspects of its Treatment. Beer Sheva: Ben Gurion University, 2018 (p. 357-397).

 

Books

1. Shvarts S & Sadetzki S (Eds.). Ringworm. Historical, Medical and Social Aspects of its Treatment. Beer Sheva: Ben Gurion University, 2018.

חזור